DOP2003000682A - CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,3-DIHIDROXI-7-METHYL-OCTIL] -AMIDE OF THE QUINOXALINE-2-CARBOXYL ACID - Google Patents

CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,3-DIHIDROXI-7-METHYL-OCTIL] -AMIDE OF THE QUINOXALINE-2-CARBOXYL ACID

Info

Publication number
DOP2003000682A
DOP2003000682A DO2003000682A DO2003000682A DOP2003000682A DO P2003000682 A DOP2003000682 A DO P2003000682A DO 2003000682 A DO2003000682 A DO 2003000682A DO 2003000682 A DO2003000682 A DO 2003000682A DO P2003000682 A DOP2003000682 A DO P2003000682A
Authority
DO
Dominican Republic
Prior art keywords
quinoxaline
amide
methyl
fluorobencil
dihidroxi
Prior art date
Application number
DO2003000682A
Other languages
Spanish (es)
Inventor
John Charles Kath
Christopher Stanley Poss
Zheng Jane Li
Zhengong Bryan Li
Eric Brock Mcelroy
Clifford Nathaniel Meltz
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2003000682A priority Critical patent/DOP2003000682A/en
Publication of DOP2003000682A publication Critical patent/DOP2003000682A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invención se refiere a formas cristalinas de [4-carbamoil-1-(3-fluorobencil)-2,7-dihidroxi-7-metil-octil]-amida del àcido quinoxalina-2-carboxilico, utiles en el tratamiento o prevención de un trastorno o afección por medio de la antagonización del receptor CCR1, y a sus metodos de preparación y uso.This invention relates to crystalline forms of [4-carbamoyl-1- (3-fluorobenzyl) -2,7-dihydroxy-7-methyl-octyl] -amide of quinoxaline-2-carboxylic acid, useful in the treatment or prevention of a disorder or condition through antagonization of the CCR1 receptor, and its methods of preparation and use.

DO2003000682A 2003-08-04 2003-08-04 CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,3-DIHIDROXI-7-METHYL-OCTIL] -AMIDE OF THE QUINOXALINE-2-CARBOXYL ACID DOP2003000682A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2003000682A DOP2003000682A (en) 2003-08-04 2003-08-04 CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,3-DIHIDROXI-7-METHYL-OCTIL] -AMIDE OF THE QUINOXALINE-2-CARBOXYL ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2003000682A DOP2003000682A (en) 2003-08-04 2003-08-04 CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,3-DIHIDROXI-7-METHYL-OCTIL] -AMIDE OF THE QUINOXALINE-2-CARBOXYL ACID

Publications (1)

Publication Number Publication Date
DOP2003000682A true DOP2003000682A (en) 2004-04-15

Family

ID=44261208

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2003000682A DOP2003000682A (en) 2003-08-04 2003-08-04 CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,3-DIHIDROXI-7-METHYL-OCTIL] -AMIDE OF THE QUINOXALINE-2-CARBOXYL ACID

Country Status (1)

Country Link
DO (1) DOP2003000682A (en)

Similar Documents

Publication Publication Date Title
PA8579601A1 (en) ANTIINFLAMMATORY COMPOUNDS OF DI AND TRIFLORURO-TRIAZOLO-PIRIDINAS
CL2006003736A1 (en) COMPOUNDS DERIVED FROM TRIAZINE OR REPLACED PYRIMIDINE, ANTAGONISTS OF THE PROKINETICINA RECEIVER 1, PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS.
WO2005102396A3 (en) Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof
UY28766A1 (en) ADDITIONAL HETEROPOLYCLIC COMPOUNDS AND THEIR USE AS ANTAGONISTS OF THE METABOTROPIC GLUTAMATE RECEIVER
ECSP045081A (en) DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
DE602004021585D1 (en) 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE FOR USE IN THE TREATMENT OF BLOOD HIGH PRESSURE
CL2007003155A1 (en) COMPOUNDS DERIVED FROM 3,7-DIAZABICICLO [3.3.0] OCTANO OR 3,7-DIAZABICICLO [3.3.1] NONANO, NEURONAL NICOTINIC RECEIVER MODULATORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CNS DISORDERS.
CR8891A (en) ANTAGONISM OF THE ACTIVITY OF THE INTERLEUQUINE RECEIVER 21
WO2007073497A3 (en) Calcium channel antagonists
BRPI0518228A (en) mitotic kinesin inhibitors and methods of use of these
BRPI0514579A (en) compound, pharmaceutical composition, use of a compound, combination of a compound and gaboxadol, and process for preparation of a compound
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
NO20034836L (en) Concentrated pyrimidines as antagonists of the corticotropin release factor (CRF)
GT200600148A (en) METHODS FOR THE TREATMENT AND PREVENTION OF FIBROSIS
EA200701845A1 (en) ROFLUMILAST FOR TREATMENT OF DIABETES MELLITUS
NO20054371L (en) Somatostatin-dopamine chimeric analogs
ATE409188T1 (en) NAPHTHYRIDINE COMPOUNDS
DE602007004999D1 (en) 1,4,5,6,7,8-HEXAHYDRO-1,2,5-TRIAZA AZULEN DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
ATE419845T1 (en) IL-8 RECEPTOR ANTAGONISTS
CL2003001415A1 (en) COMPOUNDS D DERIVED FROM NAFTIL, QUINOLINIL AND ISOQUINOLINIL UREA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND PREVENTION OF PAIN CONDITIONS AND IN THE SYRNDROME OF THE IRRITABLE COLON AND ASSOCIATED CONDITIONS.
CL2008003659A1 (en) Compounds derived from 6- (4-benzylpiperazin-1-yl) pyrimidin-4-one, modulators of the enzyme stearoyl-coa-desaturase 1; preparation procedure; pharmaceutical composition; and use in the treatment and prophylaxis of obesity.
ECSP055588A (en) CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,7-DIHIDROXI-7-METHYL-OCTIL] -AMIDA OF THE QUINOXALINE-2-CARBOXYL ACID
UY26601A1 (en) IL-8 RECEPTOR ANTAGONISTS